Liang Lu
4 Papers
Liang Lu is an academic researcher. The author has contributed to research in topics: Medicine & Fusarium. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Multiple Mutations in SDHB and SDHC2 Subunits Confer Resistance to the Succinate Dehydrogenase Inhibitor Cyclobutrifluram in Fusarium fujikuroi.
Zhaolin Xue,Shan Zhong,Jing Shen,Ye Sun,Xuheng Gao,Xiangyang Wang,Fengsheng Li,Liang Lu,Xili Liu +8 more
TL;DR: In this paper , the authors showed that cyclobutrifluram is a succinate dehydrogenase inhibitor (SDHI), which shows strong inhibitory activity against Fusarium fujikuroi.
24
Resistance Risk and Resistance-Related Point Mutation in SdhB and SdhC1 of Cyclobutrifluram in Fusarium pseudograminearum.
Yiwen Li,Yidong Tang,Ziwei Xue,Yan Na Wang,Yifei Shi,Xuheng Gao,Guixiang Li,Feng Li,Liang Lu,Jianqiang Miao,Xili Liu +10 more
TL;DR: In this article , the potential for cyclobutrifluram resistance in Fusarium pseudograminearum and the resistance mechanism involved were evaluated and it was shown that the resistance risk might be moderate.
20
Resistant risk and resistance-related point mutation in SdhC1 of pydiflumetofen in Fusarium pseudograminearum.
TL;DR: In this article , a resistance risk assessment of Fusarium pseudograminearum to pydiflumetofen and the resistance mechanism involved have not yet been investigated.
Inhibitory activity to Fusarium spp. and control potential for wheat Fusarium crown rot of a novel succinate dehydrogenase inhibitor cyclobutrifluram.
Yiwen Li,Tan Dai,Yidong Tang,Yan Wang,Xixi Wang,Zhongqiao Huang,Feng Li,Liang Lu,Jianqiang Miao,Xili Liu +9 more
TL;DR: The present investigation has revealed the tremendous potential of cyclobutrifluram as a formidable contender in the realm of fungicides, particularly in its ability to effectively combat FCR and other Fusarium-related ailments.